Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Wen Huang

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Medicina (Kaunas, Lithuania)|December 23, 2023
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational StudyHsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, et al.
Oncology Research|June 12, 2023
Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomyYung-Sung Yeh, Hsiang-Lin Tsai, Yen-Cheng Chen, et al.
Plos One|April 29, 2015
LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant ChemotherapyYun-Ting Lou, Chao-Wen Chen, Yun-Ching Fan, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
Efficacy and safety of regorafenib plus FOLFIRI with <i>UGT1A1</i> genotyping-guided irinotecan dose escalation against metastatic colorectal cancer: a multicenter, phase II, open-label, two-arm randomized controlled triaChing-Wen Huang, Yen-Cheng Chen, Tao-Wei Ker, et al.
Plos One|May 21, 2015
Two Novel Motifs of Watermelon Silver Mottle Virus NSs Protein Are Responsible for RNA Silencing Suppression and PathogenicityChung-Hao Huang, Weng-Rong Hsiao, Ching-Wen Huang, et al.
Journal of Translational Medicine|April 30, 2016
Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patientsI-Ping Yang, Hsiang-Lin Tsai, Zhi-Feng Miao, et al.
Biosensors & Bioelectronics|March 29, 2020
Improving the reproducibility, accuracy, and stability of an electrochemical biosensor platform for point-of-care useLung-Chieh Chen, Erick Wang, Chun-San Tai, et al.
Plos One|November 2, 2021
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancerYen-Cheng Chen, Hsiang-Lin Tsai, Ching-Chun Li, et al.
Investigational New Drugs|August 5, 2025
Synergistic effects of the curcumin analog HO-3867 and olaparib in transforming fallopian tube epithelial cellsCai-Chieh Tseng, Min-Hsi Ku, Wei-Min Wu, et al.
Plos One|October 16, 2020
Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapyChing-Wen Huang, Wei-Chih Su, Tzu-Chieh Yin, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Medicina (Kaunas, Lithuania)|December 23, 2023
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational StudyHsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, et al.
Oncology Research|June 12, 2023
Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomyYung-Sung Yeh, Hsiang-Lin Tsai, Yen-Cheng Chen, et al.
Plos One|April 29, 2015
LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant ChemotherapyYun-Ting Lou, Chao-Wen Chen, Yun-Ching Fan, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
Efficacy and safety of regorafenib plus FOLFIRI with <i>UGT1A1</i> genotyping-guided irinotecan dose escalation against metastatic colorectal cancer: a multicenter, phase II, open-label, two-arm randomized controlled triaChing-Wen Huang, Yen-Cheng Chen, Tao-Wei Ker, et al.
Plos One|May 21, 2015
Two Novel Motifs of Watermelon Silver Mottle Virus NSs Protein Are Responsible for RNA Silencing Suppression and PathogenicityChung-Hao Huang, Weng-Rong Hsiao, Ching-Wen Huang, et al.
Journal of Translational Medicine|April 30, 2016
Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patientsI-Ping Yang, Hsiang-Lin Tsai, Zhi-Feng Miao, et al.
Biosensors & Bioelectronics|March 29, 2020
Improving the reproducibility, accuracy, and stability of an electrochemical biosensor platform for point-of-care useLung-Chieh Chen, Erick Wang, Chun-San Tai, et al.
Plos One|November 2, 2021
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancerYen-Cheng Chen, Hsiang-Lin Tsai, Ching-Chun Li, et al.
Investigational New Drugs|August 5, 2025
Synergistic effects of the curcumin analog HO-3867 and olaparib in transforming fallopian tube epithelial cellsCai-Chieh Tseng, Min-Hsi Ku, Wei-Min Wu, et al.
Plos One|October 16, 2020
Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapyChing-Wen Huang, Wei-Chih Su, Tzu-Chieh Yin, et al.
Pageof 20